期刊文献+

大豆蛋白与动物蛋白对糖尿病肾病患者肾功能影响的Meta分析 被引量:5

Effects of soybean protein and animal protein on renal function of patients with diabetic nephropathy : a Meta-analysis
原文传递
导出
摘要 目的通过Meta分析评价大豆蛋白与动物蛋白对糖尿病肾病患者肾功能的不同影响,为临床实践提供参考。方法收集1980年1月—2011年11月间公开发表的关于糖尿病肾病摄取大豆蛋白和动物蛋白的研究文献,应用RevMan5.0录入相应资料,对相关肾脏指标进行Meta分析。结果共有5篇文献纳入研究,对相关指标进行异质性检验,根据结果分别采用随机效应模型或固定效应模型,Meta分析结果显示:大豆蛋白与动物蛋白相比,可以改善内生肌酐清除率[WMD=-11.51,95%ci(-16.37,6.65),P〈0.05]、蛋白尿[WMD=-0.96,95%c1(-1.36,-0.58),P〈0.05]、尿肌酐[WMD=-1.11,95%CI(-1.91,-0.30),P〈0.05],而对肾小球滤过率[WMD=0.28,95%CI(-0.12,0.68),P〉0.05]、血清尿素氮[WMD=-0.20,95%CI(-0.60,0.19),P〉0.05]、血清肌酐[WMD=-0.22,95%CI(-0.54,0.10),P〉0.05]的影响差异无统计学意义。结论大豆蛋白与动物蛋白相比,在改善肾脏尿液内生肌酐清除率、尿肌酐、蛋白尿等方面具有一定优势,而在肾小球滤过率方面逊于动物蛋白。 Objective To evaluate the effects of soybean protein and animal protein on renal function of patients with diabetic nephropathy. Methods In this Meta-analysis, literatures on the effects of soybean protein and animal protein on renal function of patients with diabetic nephropathy published during January 1980 and November 2011 were reviewed and analyzed quantitatively and synthetically by using Meta- analysis RevMan 5.0 software. Results Five case-control studies met the inclusive criteria and entered into random effect model. In comparison with animal protein, soybean protein significantly improved endogenous creatinine clearance rate ( weight mean difference (WMD) = - 11.51, 95% confidence interval (CI) - 16. 37 to 6. 65), proteinuria (WMD = -0. 96, 95% C1 - 1.36 to -0. 58), urine creatinine (WMD = - 1.11, 95% CI - 1.91 to - 0. 30), glomerular filtration rate ( WMD = 0. 28, 95% CI - 0. 12 to 0. 68) , serum urea nitrogen (WMD = -0. 20, 95% CI -0. 60 to 0. 19) and serum creatinine (WMD = -0. 22, 95% CI -O. 54 to 0. 10). Conclusions Soy protein seems to have potential to improve urine creatinine clearance, urine creatinine, proteinuria and serum urea nitrogen. However, animal protein may contribute to increased glomerular filtration rate.
出处 《中华健康管理学杂志》 CAS 2013年第1期31-35,共5页 Chinese Journal of Health Management
关键词 大豆蛋白质类 糖尿病肾病 META分析 动物蛋白 Soybean proteins Diabetic nephropathies Meta-analysis Animal protein
  • 相关文献

参考文献15

  • 1孙永波.糖尿病肾病发生与发展相关危险因素的研究进展[J].医学综述,2011,17(10):1531-1534. 被引量:21
  • 2Deferrari G, Ravera M, Berruti V, et al. Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. J Am Soc Nephrol,2004,15 Suppl 1 :S6-11.
  • 3Lichtenstein MJ, Mulrow CD, Elwood PC. Guidelines for reading case-control studies. J Chronic Dis, 1987,40:893-903.
  • 4Anderson JW, Blake JE, Turner J, et al. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr, 1998,68 (6 Suppl) : S1347-1353.
  • 5Azadbakht L, Shakerhosseini R, Atabak S, et al. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type ]I diabetes with nephropathy. Eur J Clin Nutr, 2003,57 : 1292 - 1294.
  • 6Teixeira SR, Tappenden KA, Carson L, et al. Isolated soy protein consumption reduces urinary albumin excretion and improves theserum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr, 2004,134 : 1874-1880.
  • 7Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care,2008,31:648-654.
  • 8Azadbakht L, Esmaillzadeh A. Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Ren Nutr,2009,19:479-486.
  • 9Anderson JW. Beneficial effects of soy protein consumption for renal function. Asia Pac J Clin Nutr,2008,17 Suppl 1:324-328.
  • 10Fanti P, Asmis R, Stephenson TJ, et al. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant, 2006,21 : 2239 -2246.

二级参考文献23

  • 1Schrier RW,Estacio RO,Mehler PS,et al.Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus:a summary of the ABCD trial[J].Nat Clin Pract Nephrol,2007,3(8):428-438.
  • 2Deferrari G,Ravera M,Berruti V,et al.Optimizing therapy in the diabetic patient with renal disease:antihypertensive treatment[J].J Am Soc Nephrol,2004,15 Suppl 1:S6-S11.
  • 3American Diabetes Association.Standards of medical care in dDiabetes--2010[J].Diabetes Care,2010,33(Suppl 1):S11-S61.
  • 4Bloomgarden ZT.Diabetic nephropathy[J].Diabetes Care,2008,31(4):823-827.
  • 5Ravid M.Dual blockade of the renin-angiotensin system in diabetic nephropathy[J].Diabetes Care,2009,32(Suppl 2):S410-S413.
  • 6Deferrari G,Ravera M,Berruti V,et al.Optimizing therapy in the diabetic patient with renal disease:antihypertensive treatment[J].J Am Soc Nephrol,2004,15(Suppl 1):S6-S11.
  • 7Robles NR,Romero B,Fernandez-Carbonero E,et al.Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy:a retrospective comparison[J].J Renin Angiotensin Aldosterone Syst,2009,10(4):195-200.
  • 8American Diabetes Association.Treatment of hypertension in adults with diabetes[J].Diabetes Care,2002,25(1):199-201.
  • 9Chudek J,Adamczak M,Karkoszka H,et al.Plasma adiponectin concentration before and after successful kidney transplantation[J].Transplant Proc,2003,35(6):2186-2189.
  • 10Fujita H,Morii T,Koshimura J,et al.Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy[J].Endocr J,2006,53(6):745-752.

共引文献27

同被引文献55

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部